Terms: = Ovarian cancer AND SERPINE1, PAI, PAI-1, PAI1, PLANH1 AND Staging
3 results:
1. Expression, Intracellular Localization, and Prognostic Value of Plasminogen Activator Inhibitor 1 and pai-1 RNA-Binding Protein 1 in Primary and Recurrent ovarian cancer: A Study of the Tumor Bank ovarian cancer Network.
Koensgen D; Stope MB; Tuerbachova I; Bruennert D; Kohlmann T; Braicu I; Sehouli J; Denkert C; Darb-Esfahani S; Stickeler E; Sofroni D; Dahl E; Mustea A
Gynecol Obstet Invest; 2018; 83(5):508-514. PubMed ID: 28738361
[TBL] [Abstract] [Full Text] [Related]
2. Analysis of potential prognostic factors in 111 patients with ovarian cancer.
Hornung R; Urs E; Serenella E; Edward W; Ursula S; Urs H; Daniel F
Cancer Lett; 2004 Mar; 206(1):97-106. PubMed ID: 15019165
[TBL] [Abstract] [Full Text] [Related]
3. Clinical value of components of the plasminogen activation system in ovarian cyst fluid.
Boss EA; Massuger LF; Thomas CM; Geurts-Moespot A; van Schaik JH; Boonstra H; Sweep CG
Anticancer Res; 2002; 22(1A):275-82. PubMed ID: 12017303
[TBL] [Abstract] [Full Text] [Related]
